Simvastatin–Fluconazole Causing Rhabdomyolysis

Aasma Shaukat(New York University), Maria R. Baer(University of Maryland, Baltimore), Georgirene D. Vladutiu(Women & Children's Hospital of Buffalo), Mustafa Beneklı, Meir Wetzler, James L. Slack(Memorial Sloan Kettering Cancer Center)

Annals of Pharmacotherapy

June 5, 2003

10.1345/aph.1c467

Cited by 57

Related Papers

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

|New England Journal of Medicine|2018|1.4k

Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML

|New England Journal of Medicine|2019|1.3k

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

|The Lancet|2021|795

<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

|Journal of Clinical Oncology|2010|764

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

|The Lancet Oncology|2017|493